Table II.

Early Virological Response (EVR) of the Two Studied Groups

EVR	Group 1 (N = 60)	Group 2 (N = 60)	P‐value
Non responders	17 (28.3%)	6 (10%)	0.011*
Responders	43 (71.7%)	54 (90%)
cEVR	42 (70%)	52 (86.7%)	0.036*
pEVR	1 (1.7%)	2 (3.3%)

Group 1 were given pegylated interferon alfa‐2a plus ribavirin. Group 2 were given hydroxychloroquine plus pegylated interferon alfa‐2a plus ribavirin. cEVR, complete early virological response; pEVR, partial early virological response. Data are expressed as number (%). Statistical analysis was carried out using χ² test. *, Significant at p ≤ 0.05 using χ² test.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.